Klein Roger M.'s Form 4 filing
Evoke Pharma Inc (EVOK) · filed Nov 7, 2025
- Accession no.
- 0001651175-25-000005
- Filed
- Nov 7, 2025
- Trade date
- Nov 6, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $95.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Klein Roger M.CIK 0001651175 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2025 | Common Stock | SSaleDisposed | −5,000 | $10.66F1 | −$53,300 | 29,000 | Indirect | |
| Nov 6, 2025 | Common Stock | SSaleDisposed | −4,000 | $10.65 | −$42,600 | 125,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Price reflects the weighted average sale price for the shares, which were sold in multiple transactions at prices that ranged from $10.65 to $10.66. Upon request, the Reporting Person will provide information regarding the number of shares sold at each price within the range to the Issuer, any security holder of the issuer, or the SEC staff.
Referenced by the price of 1 transaction in Table I.